Healthcare -
Biotechnology - NASDAQ - US
$ 2.4
-6.98 %
$ 167 M
Market Cap
-0.46
P/E
PHAT - REVENUE
Revenue PHAT - Phathom Pharmaceuticals, Inc.
55.3 M
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR